Ghent University Academic Bibliography

Your filters: cql: parent exact "Annals of Oncology"

Add to list
- Conference Paper
- C3
Current care for patients on oral anticancer therapy through a different lens : assessment from a patient and healthcare professional perspective

Ann Van Hecke (UGent) , Lise-Marie Kinnaer (UGent) , V. Foulon and Ilyse Kenis (UGent)

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S1236-S1236
Add to list
- Conference Paper
- C3
Mentoring programs for specialised and advanced practice nurses : a systematic review

Isabel Vlerick (UGent) , Elsie Decoene (UGent) , Ann Van Hecke (UGent) , Ben Delbaere, A. Coolbrandt and Lise-Marie Kinnaer (UGent)

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S1248-S1248
Add to list
- Conference Paper
- C3
Dynamics and processes influencing role integration of advanced practice nurses and nurse navigators in oncology teams

Isabel Vlerick (UGent) , Ann Van Hecke (UGent) , Soumaya Akhayad (UGent) , Elsie Decoene (UGent) , Michiel Daem (UGent) and Lise-Marie Kinnaer (UGent)

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S1250-S1250
Add to list
- Conference Paper
- C3
First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRAS G12C mutation

J. Heymach, N. Kotecki, H. Prenen, G. Alonso, C.R. Lindsay, M. Barve, C. Thamer, S. Eigenbrod-Giese, M.A. Marotti and Griet Van Lancker (UGent)

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S468-S468
Add to list
GeNeo : agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative

P. G. Aftimos, K. Punie, L. Decoster, C. Van Marcke de Lummen, A. Hebrant, G. Raicevic, E. Van Valckenborgh, B. Maes, J. Maetens, J. J. Collignon, et al.

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S253-S254
Add to list
Phase I, non-randomised, open-label, multi-centre dose escalation trial of BI 764532 (DLL3/CD3 IgG-like T cell engager [TcE]) plus ezabenlimab (anti-PD-1 antibody) in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs) expressing DLL3

J. Mazieres, M. Duruisseaux, H. Curcio, C. Morizane, R. Galot, Sylvie Rottey (UGent) , J. A. Stratmann, Y. Ma, M. Bouzaggou, L. Geng, et al.

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S1076-S1077
Add to list
- Conference Paper
- C3
Evaluating the novel combination of pressurized intraperitoneal aerosol chemotherapy-oxaliplatin (PIPACOX) as an immunomodulator in combination with systemic nivolumab for gastric cancer peritoneal metastases

R. Sundar, D. Chia, Wim Ceelen (UGent) , C. Chia, G. Kim, A. Shabbir, W. Willaert, J. Ong, J. Wong, C. J. Seo, et al.

(2023) ANNALS OF ONCOLOGY. In Annals of Oncology 34(Supplement 2). p.S869-S869
Add to list
- Journal Article
- A1
- open access
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

P A Sutera, A C Shetty, A Hakansson, Karlien Van der Eecken (UGent) , Y Song, Y Liu, J Chang, Valerie Fonteyne (UGent) , A A Mendes, Nicolaas Lumen (UGent) , et al.

(2023) ANNALS OF ONCOLOGY. 34(7). p.605-614
Add to list
Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer

A. J. Murtha, E. Warner, Kim Van der Eecken (UGent) , E. Kwan, C. Herberts, J. Sipola, S. Ng, E. Chen, N. Fonseca, E. Schonlau, et al.

(2022) ANNALS OF ONCOLOGY. In Annals of Oncology 33(8, Supplement 8). p.S1384-S1384
Add to list
- Journal Article
- A1
- open access
European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer

I. Vergote, A. González-Martín, I. Ray-Coquard, P. Harter, N. Colombo, P. Pujol, D. Lorusso, M.R. Mirza, B. Brasiuniene, R. Madry, et al.

(2022) ANNALS OF ONCOLOGY. 33(3). p.276-287

Academic Bibliography

Current care for patients on oral anticancer therapy through a different lens : assessment from a patient and healthcare professional perspective

Mentoring programs for specialised and advanced practice nurses : a systematic review

Dynamics and processes influencing role integration of advanced practice nurses and nurse navigators in oncology teams

First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRAS G12C mutation

GeNeo : agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative

Phase I, non-randomised, open-label, multi-centre dose escalation trial of BI 764532 (DLL3/CD3 IgG-like T cell engager [TcE]) plus ezabenlimab (anti-PD-1 antibody) in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs) expressing DLL3

Evaluating the novel combination of pressurized intraperitoneal aerosol chemotherapy-oxaliplatin (PIPACOX) as an immunomodulator in combination with systemic nivolumab for gastric cancer peritoneal metastases

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer

European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer

Contents

Support

Contact